应用定量CT影像特征分析预测卵巢癌患者化疗反应
该回顾性研究纳入91例卵巢癌患者,利用计算机辅助检测方案分割CT上的转移性肿瘤并计算影像特征,比较仅基于治疗前CT特征与基于治疗前后CT特征差值的两种定量影像标志物预测6个月无进展生存的效能,并与RECIST标准对比。结果显示基于特征差值的融合标志物AUC最高(0.829±0.043),预测准确率80.2%,高于仅用治疗前特征的71.4%和RECIST的74.7%。
要点
- 基于治疗前后CT特征差值的融合影像标志物预测6个月无进展生存的AUC为0.829±0.043,准确率80.2%。
- 仅用治疗前CT特征的融合标志物AUC为0.810±0.045,准确率71.4%,低于特征差值标志物。
- RECIST标准的总体预测准确率为74.7%,低于两种定量影像标志物。
核心结论
- 本研究证明使用治疗前CT图像计算的定量影像标志物预测卵巢癌患者化疗反应具有可行性,但使用治疗前后CT图像特征差值可获得更高的预测准确率。
研究设计与样本
- 回顾性研究,纳入91例卵巢癌患者,每例均有治疗前和治疗后两套CT图像;采用计算机辅助检测方案分割放射科医生先前在CT上追踪的转移性肿瘤并计算影像特征;构建两个初始特征池(仅治疗前CT特征池和治疗前后CT特征差值池),经特征选择后用等权融合方法生成定量影像标志物,预测6个月无进展生存,并与RECIST标准比较预测准确率。
诊断标准与关键数值
- 仅用治疗前CT图像的单个影像特征预测6个月无进展生存的AUC最高为0.684±0.056;用治疗前后CT图像特征差值的单个影像特征AUC最高为0.771±0.050;两个对应的融合影像标志物AUC分别显著提高至0.810±0.045和0.829±0.043(P < 0.05);两个影像标志物和RECIST的总体预测准确率分别为71.4%、80.2%和74.7%。
临床应用与阅片要点
- 作者认为使用治疗前CT图像计算的定量影像标志物预测化疗反应具有可行性,但使用治疗前后CT图像特征差值可获得更高的预测准确率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: The study aimed to investigate the role of applying quantitative image features computed from computed tomography (CT) images for early prediction of tumor response to chemotherapy in the clinical trials for treating ovarian cancer patients.
MATERIALS AND METHODS: A dataset involving 91 patients was retrospectively assembled. Each patient had two sets of pre- and post-therapy CT images. A computer-aided detection scheme was applied to segment metastatic tumors previously tracked by radiologists on CT images and computed image features. Two initial feature pools were built using image features computed from pre-therapy CT images only and image feature difference computed from both pre- and post-therapy images. A feature selection method was applied to select optimal features, and an equal-weighted fusion method was used to generate a new quantitative imaging marker from each pool to predict 6-month progression-free survival. The prediction accuracy between quantitative imaging markers and the Response Evaluation Criteria in Solid Tumors (RECIST) criteria was also compared.
RESULTS: The highest areas under the receiver operating characteristic curve are 0.684 ± 0.056 and 0.771 ± 0.050 when using a single image feature computed from pre-therapy CT images and feature difference computed from pre- and post-therapy CT images, respectively. Using two corresponding fusion-based image markers, the areas under the receiver operating characteristic curve significantly increased to 0.810 ± 0.045 and 0.829 ± 0.043 (P < 0.05), respectively. Overall prediction accuracy levels are 71.4%, 80.2%, and 74.7% when using two imaging markers and RECIST, respectively.
CONCLUSIONS: This study demonstrated the feasibility of predicting patients' response to chemotherapy using quantitative imaging markers computed from pre-therapy CT images. However, using image feature difference computed between pre- and post-therapy CT images yielded higher prediction accuracy.
引用
- Danala G, Thai T, Gunderson CC, et al. Applying Quantitative CT Image Feature Analysis to Predict Response of Ovarian Cancer Patients to Chemotherapy. Acad Radiol. 2017. PMID: 28554551. doi:10.1016/j.acra.2017.04.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。